Institute for OneWorld Health to exhibit at BIO
...Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., will be available at the BIO 2005 Annual International Convention to discuss how the biotechnology industry can partner in the company's innovative approaches to develop safe, effective and affordable new medicines for people wit...Georgia Tech develops mass spectrometry device that analyzes proteins faster and at a lower cost
...his innovation will be particularly useful for the pharmaceutical industry. Drugs target certain proteins to achieve their designed effect on the body. The pharmaceutical industry must test large numbers compounds on even larger numbers of proteins to determine what effe...UCLA awarded more than $6 million for biodefense and infectious disease research
...ery of restriction enzymes, a fundamental tool for pharmaceutical and biotechnology companies, was the result of pur...rom that discovery is an indispensable tool in the pharmaceutical and biotechnology industry. "In addition, knowledge of the genomes of bacterial pathogens required m...Clear rules needed to govern deep sea bioprospecting: UNU
...ientists and companies bioprospecting for possible pharmaceutical or industrial applications. Already several valua...products. Nevertheless, the report says all major pharmaceutical firms, including Merck, Lilly, Pfizer, Hoffman-Laroche and Bristol-Myers Squibb, have marine biology...NIH awards $10.4 million to Scripps Research Institute and Scripps Florida
... "This sort of work has traditionally been done by pharmaceutical companies, never before in the public/non-profit s...ment in academic laboratories or in the biotech or pharmaceutical sectors because some of them may show some degree of efficacy against a particular target. These cou...Fragment of yellow fever virus may hold key to safer vaccine
...or for therapy, but ter Meulen does not think that pharmaceutical companies are likely to take this approach. More realistically, he said, the findings could help manufacturers design a more consistent vaccine based on recombinant genetic technology, without the potential side effects from variations of the weakene...Chemical Society announces EPA awards for environmentally friendly technologies
...and other cancer treatments. At the same time, the pharmaceutical giant introduced a new method to make the drug's active ingredient, aprepitant, that reduces process waste by more than 80 percent. The researchers later developed a new process, which requires half the number of steps, doubles the overall yield and ...France's highest scientific honor awarded this year to Salk Institute scientist Ronald M. Evans
...vation technique has been deployed in nearly every pharmaceutical company and has led to the discovery, development and approval of drugs for the treatment of cancer, obesity and osteoporosis. His lab's research on vitamin A signaling has been key to defining the vitamin's central role in gene regulation, embryonic...Elderly mice yield clues to the process of growing old
...If that pans out, then we can begin to think about pharmaceutical interventions to retard aging by preserving mitochondrial function."...Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy
.... A common chemical used in the manufacturing and pharmaceutical industries can repair damage to cardiac muscle cell membranes and prevent heart failure in mice with the genetic mutation that causes Duchenne muscular dystrophy, according to scientists at the University of Michigan Medical School. The mutation in ...OT, VP studied as novel psychiatric drug sources; consider gender-specific drug models
...es these two substances play inside the brain. The pharmaceutical industry has been very successful in developing me... novel antidepressants and anxiolytics. The French pharmaceutical company, Sanofi-Synthelabo, has already begun to test the first V3 antagonist in human clinical tria...Researchers identify gene's role in suppressing longevity
...T1, might also promote longevity. For that reason, pharmaceutical companies are exploring drugs that influence SIRT1 activity, said Alt, who is also scientific director of the CBR Institute for Biomedical Research in Boston. Alt and his colleagues have been exploring the entire seven-member family of SIRT genes bec...Scientists discover that three molecules may be developed into new Alzheimer's drugs
...d that this work is of a type usually performed by pharmaceutical companies, but in this case was completed in an academic environment....Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
...t from the 5-LO inhibitors previously evaluated by pharmaceutical companies. Galileo's first 5-LO inhibitor is scheduled to enter clinical trials in 2006 as a potential treatment for asthma....Any exposure to tobacco smoke during pregnancy is risky
...-Womens Research Institute. "Perhaps, like certain pharmaceutical warnings, it would be appropriate to caution women to quit smoking if they are pregnant or likely to become pregnant. It is equally imperative that workplace protection be offered to reduce passive exposure."...Discovery could be key to bioterrorism defense
...in has utility as a vaccine, in the development of pharmaceutical compositions and in diagnostic assays. The second patent application, "Compositions and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses," covers the use of a novel peptide sequence of the soluble F glycoprotein, to block fusion of th......port from harvesting in the field to marketing the pharmaceutical product. This includes assisting with the science...re extensive, not only to Welsh bioscience and the pharmaceutical industry, but also to the ageing population."...UW-Madison scientists zero in on drugs' sweet spots
...ed by University of Wisconsin-Madison professor of pharmaceutical sciences Jon S. Thorson, describes a series of exp...d help make natural products more appealing to the pharmaceutical industry. Despite the fact that 60-75 percent of drugs approved to treat infectious disease and canc......e are now progressing these studies further with a pharmaceutical company." "This compound potentially represents a new approach for treating people with or at risk of heart disease at the source of the problem in the vessel wall. Vitamin E is not depleted or deficient in people with heart disease. It is in my v...Cells direct membrane traffic by channel width, scientists say
...anding the principles could provide new, effective pharmaceutical targets to control the channels to help treat disease. Study co-authors were group director Klaus Schulten and Yi Wang, a doctoral student in molecular and cell biology....